Loading profile
Loading sourced facts.
01 Finding sources
02 Reading evidence
03 Filing the card
Loading profile
01 Finding sources
02 Reading evidence
03 Filing the card
Evozyne uses generative AI to design novel therapeutic proteins for drug discovery and carbon capture.
Raised $144M across disclosed rounds.[1][6]
Series B closed September 2023, led by OrbiMed.[2][3][7]
post-money valuation is not publicly disclosed.
Named investors include OrbiMed, Fidelity Management & Research Company, NVentures (NVIDIA), Paragon Biosciences, Valor Equity Partners.[2][3][7]
Rama Ranganathan, Co-Founder, Chief Scientist[3][11]
Andrew Ferguson, Co-Founder, Head of Computation[3][11]
Marc Yoskowitz, Chief Executive Officer[6][8][9][10][13][14]
Arjun Rallapalli, Chief Operating Officer[6][8][9][10][13][14]
Gary Krishnan, Chief Scientific Officer[6][8][9][10][13][14]
Uri Herzberg, Chief Drug Discovery Officer[6][8][9][10][13][14]
Evozyne uses generative AI to design novel therapeutic proteins for drug discovery and carbon capture.
Ask for one referenceable production customer.
Not a recommendation. The first thing this ledger cannot answer.
Csaba Pazmany, Senior Director of Business Development[6][8][9][10][13][14]
Ryan Mork, Senior Director of Data Science[6][8][9][10][13][14]
Genesis Therapeutics · genesistherapeutics.com · Named in the same market context as Evozyne in Pharmaceutical Technology coverage of generative AI drug discovery; both raised Series B rounds in 2023 with NVIDIA participation.[2]
Recursion · recursion.com · Named alongside Evozyne in Endpoints coverage as a life sciences startup touting AI in next-generation drug discovery; NVIDIA invested in both.[3]
Isomorphic Labs · isomorphiclabs.com · Named alongside Evozyne in Endpoints coverage as a comparable AI-driven drug discovery startup competing for the same pharma partnership budgets.[3]
Atomwise · atomwise.com · Named alongside Evozyne in Endpoints coverage as a comparable AI-driven drug discovery startup in the same competitive set.[3]
The customer proof is company-sourced only. No independent source in this ledger confirms it.[8]
Ask for one referenceable production customer.
Not a recommendation. The first thing this ledger cannot answer.
Filled in the side panel for invited readers. This card carries sourced facts only.
Aug 2026 · evozyne.com
company